| Dr Saud Alsubait, | |
|
401 W Greenlawn Ave, Lansing, MI 48910-2819 | |
| (517) 975-9500 | |
| (517) 975-9520 |
| Full Name | Dr Saud Alsubait |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 401 W Greenlawn Ave, Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518341494 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301115802 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saud Alsubait, 804 Service Rd Ste A109f, East Lansing, MI 48824-7015 Ph: (517) 884-2976 | Dr Saud Alsubait, 401 W Greenlawn Ave, Lansing, MI 48910-2819 Ph: (517) 975-9500 |
News Archive
Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company's flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward's Empirica Suite of pharmacovigilance and risk management products.
Southern Research Institute today announced a new service offering - a novel in vitro 12-cell line panel assay designed to predict drug activity and improve the success rate of drugs tested in xenograft models.
One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.
A lot of our medicines and other bioactive drugs are based on chemical structures called "enantiomers"- molecules that are mirror images of each other and are non-superimposable. Notable among them are chiral N,N-acetals contained in diuretic drugs like bendroflumethiazide and thiabutazide, used to treat high blood pressure and edema.
› Verified 6 days ago
Aline De Quadros Teixeira, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1200 E Michigan Ave Ste 500, Lansing, MI 48912 Phone: 517-364-5184 | |
Dr. Harry James Mccoy, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1540 Lake Lansing Rd, Ste 201, Lansing, MI 48912 Phone: 517-913-3900 Fax: 517-913-3901 | |
Ali H. Sheikh, D.O Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1140 E Michigan Ave Ste 400, Lansing, MI 48912 Phone: 517-364-9650 Fax: 517-364-9605 | |
Georgette Nader, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-253-8366 | |
Salma Mohamed, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-1000 | |
Dr. Cynthia S. Boynton, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1540 Lake Lansing Rd, Ste 201, Lansing, MI 48912 Phone: 517-913-3900 Fax: 517-913-3901 | |
Fadi Mohammadsaeed S Alreefi, M.D Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1140 E Michigan Ave Ste 400, Lansing, MI 48912 Phone: 419-921-2531 Fax: 517-364-9605 |